Biophysical Properties in Glaucoma Diagnostic Technologies /
This book provides an overview on new insights in glaucoma, the latest technological developments, scientific achievements, and novel research leading to new paradigms in glaucoma diagnosis. Readers will discover a broad picture starting from theoretical perspectives in diagnostic criteria followed...
Corporate Author: | |
---|---|
Other Authors: | , |
Format: | Electronic eBook |
Language: | English |
Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
Edition: | 1st ed. 2019. |
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Table of Contents:
- Introduction
- 1. Importance of intraocular, intracranial and ocular prefusion pressures ( IOP, ICP, OPP) in the pathogenesis of glaucoma
- 1.1 Intraocular pressure as a risk factor
- 1.2 Intracranial pressure as a risk factor
- 1.3 Ocular perfusion pressure as a risk factor
- 1.4 Translaminar pressure difference
- 1.5 Translaminar pressure gradient
- 1.6 Lamina cribrosa (galima ir prie TPG rasyt)
- 1.7 Interactions between IOP, ICP, OPP
- 2. Current visualization of anterior chamber angle
- 2.1.Possibilities in anterior segment imaging for glaucoma (UBM, AS-OCT, gonioscopy: advantages and disadvantages)
- 2.2. Clinical applications in medical practice: Visualisation of anterior chamber angle, Visualisation of Schlemm`s canal, Visualisation of filtering blebs
- 3. Optic nerve and retina visualization in glaucoma
- 3.1. Imaging techniques of the optic nerve head and retinal fiber layer
- 3.2 Changes of retinal nerve fiber layer
- 3.3 Optic nerve head visualization
- 3.4. OCT - angiography appliance in glaucoma
- 4. Visual field assessment in glaucoma
- 4.1 Visual field examination
- 4.2. Principles of visual field testing
- 4.3. Visual field loss in glaucoma
- 4.4. Static automated perimetry
- 4.5. Visual field test interpretation
- 4.6. Visual function specific perimetry tests (FDT, SWAP)
- 5. Structure and function congruency in glaucoma
- 5.1. Structural loss
- 5.2. Functional loss
- 5.3. Correlations between structure and function in glaucomatous damage
- 6. Ocular surface and glaucoma
- 6.1. Ocular surface anatomy and physiology
- 6.2. Ocular surface evaluation prior to glaucoma medical treatment
- 6.3. Glaucoma medication effect to ocular surface: toxicity, allergy, inflammation
- 6.4. Additional substances to glaucoma medication: preservative free treatment
- 6.5. Glaucoma: comorbidity with dry eye disease.